切换至 "中华医学电子期刊资源库"

中华胃食管反流病电子杂志 ›› 2020, Vol. 07 ›› Issue (01) : 36 -40. doi: 10.3877/ cma.j.issn.2095-8765.2020.01.003

所属专题: 文献

论著

唾液胃蛋白酶对胃食管反流病食管外表现的诊断价值研究
游婷1, 王雯1,(), 王蓉1, 柳刚1, 林燕芳1   
  1. 1. 350025 福州,联勤保障部队第九〇〇医院消化内科
  • 收稿日期:2019-10-05 出版日期:2020-02-15
  • 通信作者: 王雯
  • 基金资助:
    福建省自然科学基金资助项目(2016J01473)

The diagnostic value of salivary pepsin for extra-esophageal manifestations of gastroesophageal reflux disease

Ting You1, Wen Wang1,(), Rong Wang1, Gang Liu1, Yanfang Lin1   

  1. 1. Department of Gastroenterology, 900 Hospital of the Joint Logistics Team, Fuzhou 350025, China.
  • Received:2019-10-05 Published:2020-02-15
  • Corresponding author: Wen Wang
  • About author:
    Corresponding author: Wang Wen, Email:
引用本文:

游婷, 王雯, 王蓉, 柳刚, 林燕芳. 唾液胃蛋白酶对胃食管反流病食管外表现的诊断价值研究[J/OL]. 中华胃食管反流病电子杂志, 2020, 07(01): 36-40.

Ting You, Wen Wang, Rong Wang, Gang Liu, Yanfang Lin. The diagnostic value of salivary pepsin for extra-esophageal manifestations of gastroesophageal reflux disease[J/OL]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2020, 07(01): 36-40.

目的

探索唾液胃蛋白酶对胃食管反流病食管外表现的诊断价值。

方法

收集2017年3月至2018年1月就诊于联勤保障部队第九〇〇医院消化内科确诊为胃食管反流病(GERD)食管外表现的患者15例(E组)及无明显反流症状的健康志愿者15例(C组)。所有受试对象均经胃食管反流病量表(GerdQ)评分、咽喉反流症状指数评分量表(RSI)、咽喉反流体征评分量表(RFS)及24 h多通道食管腔内阻抗-pH监测(MII-pH)确诊。所有受试对象分别于晨起空腹、午餐后2 h、晚餐后2 h、症状时4个时间点收集唾液标本,用酶联免疫吸附剂法测定胃蛋白酶的浓度。分别采用单因素方差分析和LSD-t检验比较分析组间、组内各时间点唾液胃蛋白酶浓度的变化。

结果

C组、E组的唾液胃蛋白酶浓度分别为(63.59±14.34)ng/ml、(128.98±17.28)ng/ml,E组唾液胃蛋白酶浓度明显高于C组(P<0.05)。对比C组、E组间各时间点的唾液胃蛋白酶浓度,发现各时间点E组唾液胃蛋白酶浓度均明显高于C组,(P<0.05对比C组、E组内不同时间点的唾液胃蛋白酶浓度,发现C组内不同时间点的唾液胃蛋白酶浓度无显著差异;E组内晨起空腹、午餐后2 h、晚餐后2 h及症状时的唾液胃蛋白酶浓度分别为(124.28±17.50)ng/ml、(143.54±12.60)ng/ml、(122.00±15.77)ng/ml、(126.10±12.60)ng/ml。不同时间点的唾液胃蛋白酶浓度存在显著差异,(P<0.05)。其中,午餐后2 h的唾液胃蛋白酶浓度最高,将晨起空腹、晚餐后2 h、症状发生时的唾液胃蛋白酶浓度与午餐后2 h比较,(P<0.05)。而E组其他时间点之间的唾液胃蛋白酶浓度无显著差异。

结论

唾液胃蛋白酶对诊断胃食管反流病食管外表现有较好的临床价值,该类患者各时间点的唾液胃蛋白酶浓度均明显升高。其中,午餐后2 h的唾液标本的诊断价值最高。

Objective

We aimed to explore the diagnostic value of salivary pepsin forextra-esophageal manifestations of gastroesophageal reflux disease (GERD).

Methods

Studies were performed in fifteen healthy volunteers (groupC)and fifteen patients(group E)confirmed by GerdQ, reflux symptom index(RSI), reflux finding score patients(RFS) and 24-hour multichannel intraluminal impedance pH (24 h MII-pH).Saliva were collected on waking time and 2 hours after lunch and dinner as well as uncomfortableness. Salivary pepsin was analyzed by ELISA. Based on the differences in salivary pepsin, the diagnostic value of it was discussed.

Results

The concentration of salivary pepsin was 63.59±14.34 ng/ml in group C and 128.98±17.28 ng/ml in group E, and the date in group E was significantly higher than that in group C(P=0.000). While comparing the level of salivary pepsin during different timeframes between group C and E, those of group E were always higher than those of group C(p=0.000). To compare the salivary pepsin during different timeframes in group C and E separately, there was no significant difference in group C. But, significant differences were found in group E. The salivary pepsin was 124.28±17.50 ng/ml on waking time, and 143.54±12.60 ng/ml two hours after lunch, and 122.00±15.77 ng/ml two hours after dinner, and 126.10±12.60 ng/ml when uncomfortableness. It was highest when it was collected two hours after lunch. Compared with that on waking time and two hours after dinner as well as uncomfortableness, it was always significantly higher (p=0.003, 0.001, 0.008).

Conclusions

Salivary pepsin has prominent diagnostic value for extra-esophageal manifestations of GERD. The level of salivary pepsin for extra-esophageal manifestations of GERD always increases significantly anytime, but it has the greatest diagnostic significance when the saliva collected two hours after lunch, probably due to the immediate post-lunch nap.

表1 胃食管反流病量表(GerdQ)
表2 咽喉反流症状指数评分量表(RSI)
表3 咽喉反流体征评分量表(RFS)
表4 两组间唾液胃蛋白酶浓度比较(±s,ng/ml)
表5 两组不同时间点的唾液胃蛋白酶浓度比较 ±s,ng/ml
1
屈坤鹏, 成院舟. 我国部分地区胃食管反流病患病率的Meta分析 [J/CD]. 中华胃食管反流病电子杂志, 2015, 02(01): 34-44.
2
Chung H, Chon YE, Kim SU, et al. Noninvasive prediction of erosive esophagitis using a contro11ed attenuation parameter(CAP)-based risk estimation model [J]. Dig Dis Sci, 2016, 61: 507-516.
3
Kim KM, Cho YK, Bae SJ, et a1. Prevalence of gastroesophagea1 reflux disease in Korea and associated health-care utilization: a national popu-lation-based study [J]. J Gastroenterol Hepato1, 2012, 27: 741-745.
4
E1-Serag HB, Sweet S, Winchester CC, et a1.Update on the epidemi-o1ogy of gastro-oesophageal reflux disease: a systematic review [J]. Gut, 2014, 63: 871-880.
5
王晓巍,倪道凤.胃食管反流与慢性咽喉炎 [J].中华耳鼻咽喉科杂志,2004, 39(01): 55-58.
6
Johnston N, Effects Robert J., diagnosis and management of extra-esophageal reflux New York: Nova Science Publishers, 2010.
7
Roberts N B. Review article: human pepsins-their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther, 2006, NaN: 2-9.
8
Yufera M, Moyano F J, Astola A, et al. Acidic digestion in a teleost:postprandial and circadian pattern of gastric pH,pepsin activity,and pepsinogen and proton pump MRNAS expression [J]. PLOS One, 2012, 07(03): e33687.
9
Johnston N, Dettmar P W, Bishwokarma B, et al. Activity/Stability of Human Pepsin: Implications for RefluxAttributed Laryngeal Disease [J]. The Laryngoscope, 2007, 117(06): 1036-1039.
10
Hayat JO, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease [J]. Oesophagus, 2015, 64(03): 373-380.
11
Sereg-Bahar, Jerin, Jansa R, et al.Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux-a prospective comparative study [J].Clin Otolaryngol, 2015, 40(03): 234-239.
12
Du X , Wang F , Hu Z , et al. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China [J]. Bmc Gastroenterology, 2017, 17(01): 107.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[3] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[6] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[7] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[8] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[9] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[13] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[14] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[15] 俞悦, 王缘, 桑穆惠, 时钦. 基于眩晕病病机证素辨证诊断量表分析眩晕病病机证素分布规律[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 454-458.
阅读次数
全文


摘要